Yayın:
Evaluation of long-term pulmonary functions after COVID-19 infection in children: A longitudinal observational cohort study

dc.contributor.authorKorkmaz, Muhammet F.
dc.contributor.authorSenkan, Gülsüm E.
dc.contributor.authorBozdemir, Sefika Elmas
dc.contributor.authorKorkmaz, Merve
dc.contributor.authorKoç, İbrahim
dc.contributor.authorOral, Behiye
dc.contributor.buuauthorKORKMAZ, MERVE
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridMYK-5362-2025
dc.date.accessioned2025-10-21T09:41:58Z
dc.date.issued2024-12-01
dc.description.abstractIntroduction: We aimed to present the changes that may occur in pulmonary functions in children who experienced more severe coronavirus disease 2019 (COVID-19) during long-term follow-up. Methodology: A prospective longitudinal observational cohort study was conducted with 34 pediatric patients (7-18 years) who were hospitalized with COVID-19 infection (moderate n = 25, severe n = 9), and followed up at our Pediatric Infection Outpatient Clinic for approximately two years. Pulmonary function tests (PFTs) were performed using spirometry. Results: Data from the hospitalization period revealed no significant differences between the severity groups in terms of demographic, clinical, laboratory, radiological, treatment, and outcome (p > 0.05). The median time interval between COVID-19 infection and PFTs was 15 months (range 11-29 months), and there was no significant difference between severity groups (p = 0.878). Eight patients (24%) had abnormal pulmonary functions; among them, seven had an obstructive pattern (21%) and one had a restrictive pattern (3%). The severity groups had no statistical difference in pulmonary functions (p = 0.105). While forced expiratory volume in 1 second (FEV1) %, FEV1/forced vital capacity (FVC)%, and forced expiratory flow during the middle half of FVC (FEF25-75%) ratios were lower in the severe patient group, Z-scores were similar. Among the patients continuing polyclinic follow-up, 41% had persistent respiratory symptoms before PFTs. No differences were observed in PFTs when compared based on the presence of symptoms (p > 0.05). Conclusions: We observed no significant long-term differences in pulmonary function between moderate and severe COVID-19 cases in children.
dc.identifier.doi10.3855/jidc.20123
dc.identifier.endpageS274
dc.identifier.issn1972-2680
dc.identifier.issue12
dc.identifier.scopus2-s2.0-85216997031
dc.identifier.startpageS267
dc.identifier.urihttps://doi.org/10.3855/jidc.20123
dc.identifier.urihttps://hdl.handle.net/11452/56146
dc.identifier.volume18
dc.identifier.wos001421086300007
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherJ Infection Developing Countries
dc.relation.journalJournal of Infection in Developing Countries
dc.subjectCOVID-19
dc.subjectLong-COVID
dc.subjectChildren
dc.subjectPulmonary function
dc.subjectSpirometry
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectInfectious Diseases
dc.titleEvaluation of long-term pulmonary functions after COVID-19 infection in children: A longitudinal observational cohort study
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication8dcac10d-728b-4936-be4e-e23eddaf8c00
relation.isAuthorOfPublication.latestForDiscovery8dcac10d-728b-4936-be4e-e23eddaf8c00

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Korkmaz_2025.pdf
Boyut:
681.73 KB
Format:
Adobe Portable Document Format